Online inquiry

IVTScrip™ mRNA-Human ADGRD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8935MR)

This product GTTS-WK8935MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRD2 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq XM_006717348.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 347088
UniProt ID Q7Z7M1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8935MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK6002MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Synaptophysin
GTTS-WK23191MR IVTScrip™ mRNA-Human ARHGAP26, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP26
GTTS-WK10739MR IVTScrip™ mRNA-Human ADGRE5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRE5
GTTS-WK24803MR IVTScrip™ mRNA-Human ASCC2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ASCC2
GTTS-WK14930MR IVTScrip™ mRNA-Human ANKRD50, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD50
GTTS-WK15514MR IVTScrip™ mRNA-Human ANKRD28, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD28
GTTS-WK23532MR IVTScrip™ mRNA-Human ARL1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARL1
GTTS-WK28679MR IVTScrip™ mRNA-Human ARRDC2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARRDC2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW